 | Up a level |
Martelli, Maurizio; Ceriani, Luca; Ciccone, Giovannino; Ricardi, Umberto; Kriachok, Iryna; Botto, Barbara; Balzarotti, Monica; Tucci, Alessandra; Usai, Sara Veronica; Zilioli, Vittorio Ruggero; Pennese, Elsa; Arcaini, Luca; Dabrowska-Iwanicka, Anna; Ferreri, Andrés Jm; Merli, Francesco; Zhao, Weili; Rigacci, Luigi; Cellini, Claudia; Hodgson, David; Ionescu, Codruta; ... (2024). Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. (In Press). Journal of clinical oncology(JCO2401373), JCO2401373. American Society of Clinical Oncology 10.1200/JCO-24-01373
Stathis, Anastasios; Pirosa, Maria Cristina; Orsucci, Lorella; Feugier, Pierre; Tani, Monica; Ghesquières, Hervé; Musuraca, Gerardo; Rossi, Francesca Gaia; Merli, Francesco; Guièze, Romain; Gyan, Emmanuel; Gini, Guido; Marino, Dario; Gressin, Remy; Morschhauser, Franck; Cavallo, Federica; Palombi, Francesca; Conconi, Annarita; Tessoulin, Benoît; Tilly, Hervé; ... (2024). IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica - the hematology journal, 109(8), pp. 2564-2573. Ferrata-Storti Foundation 10.3324/haematol.2023.283918
Ferreri, Andreas J M; Illerhaus, Gerald; Doorduijn, Jeanette K; Auer, Dorothee P; Bromberg, Jacoline E C; Calimeri, Teresa; Cwynarski, Kate; Fox, Christopher P; Hoang-Xuan, Khê; Malaise, Denis; Ponzoni, Maurilio; Schorb, Elisabeth; Soussain, Carole; Specht, Lena; Zucca, Emanuele; Buske, Christian; Jerkeman, Mats; Dreyling, Martin (2024). Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. HemaSphere, 8(6) Wolters Kluwer Health 10.1002/hem3.89
Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; ... (2023). Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine, 64, p. 102221. Elsevier 10.1016/j.eclinm.2023.102221
Ceriani, Luca; Zucca, Emanuele (2022). Dmax: A simple and reliable PET/CT-derived new biomarker of lymphoma outcome? Hematological oncology, 40(5), pp. 843-845. Wiley 10.1002/hon.3049
Alderuccio, Juan Pablo; Reis, Isildinha M; Habermann, Thomas M; Link, Brian K; Thieblemont, Catherine; Conconi, Annarita; Larson, Melissa C; Cascione, Luciano; Zhao, Wei; Cerhan, James R; Zucca, Emanuele; Lossos, Izidore S (2022). Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. American journal of hematology, 97(12), pp. 1529-1537. Wiley-Liss 10.1002/ajh.26715
Vannata, Barbara; Pirosa, Maria Cristina; Bertoni, Francesco; Rossi, Davide; Zucca, Emanuele (2022). Bacterial infection-driven lymphomagenesis. Current opinion in oncology, 34(5), pp. 454-463. Lippincott Williams & Wilkins 10.1097/CCO.0000000000000886
Stathis, Anastasios; Mey, Ulrich J M; Schär, Sämi; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; ... (2022). SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances, 6(13), pp. 3911-3920. American Society of Hematology 10.1182/bloodadvances.2021006520
Genta, Sofia; Ghilardi, Guido; Cascione, Luciano; Juskevicius, Darius; Tzankov, Alexandar; Schär, Sämi; Milan, Lisa; Pirosa, Maria Cristina; Esposito, Fabiana; Ruberto, Teresa; Giovanella, Luca; Hayoz, Stefanie; Mamot, Christoph; Dirnhofer, Stefan; Zucca, Emanuele; Ceriani, Luca (2022). Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers, 14(4) MDPI AG 10.3390/cancers14041018
Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386
Pirosa, Maria C; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios (2022). A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Leukemia & lymphoma, 63(1), pp. 117-123. Taylor & Francis 10.1080/10428194.2021.1966780
Moccia, Alden Alberto; Schär, Sämi; Hayoz, Stefanie; Pirosa, Maria Cristina; Taverna, Christian; Novak, Urban; Kimby, Eva; Ghielmini, Michele; Zucca, Emanuele (2021). Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK). British journal of haematology, 192(6), pp. 1031-1034. Wiley-Blackwell 10.1111/bjh.17045
Ferreri, Andrés J M; Doorduijn, Jeanette K; Re, Alessandro; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Luppi, Mario; Calimeri, Teresa; Cattaneo, Chiara; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2021). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. The Lancet. Haematology, 8(2), e110-e121. Elsevier 10.1016/S2352-3026(20)30366-5
Moccia, Alden A; Taverna, Christian; Schär, Sämi; Vanazzi, Anna; Rondeau, Stéphanie; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Ruegsegger, Céline; Biaggi Rudolf, Christine; Rusterholz, Corinne; Hayoz, Stefanie; Ghielmini, Michele and Zucca, Emanuele (2020). Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood advances, 4(23), pp. 5951-5957. American Society of Hematology 10.1182/bloodadvances.2020002858
Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J. M.; Rauch, Daniel; Wahlin, Björn E.; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J. M.; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; ... (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), pp. 353-362. American Society of Hematology 10.1182/blood-2018-10-879643
Ferreri, Andres JM; Doorduijn, Jeanette K.; Cattaneo, Chiara; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Narni, Franco; Calimeri, Teresa; Re, Alessandro; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2019). Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial. Blood, 134(Suppl. 1), p. 353. American Society of Hematology 10.1182/blood-2019-129835
Conconi, Annarita; Zucca, Emanuele; Margiotta-Casaluci, Gloria; Darling, Katharine; Hasse, Barbara; Battegay, Manuel; Staehelin, Cornelia; Novak, Urban; Schmid, Patrick; Scherrer, Alexandra; Dirnhofer, Stephan; Kwee, Ivo; Nassi, Luca; Cavalli, Franco; Gaidano, Gianluca; Bertoni, Francesco; Bernasconi, Enos (2018). Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology, 36(5), pp. 757-764. Wiley 10.1002/hon.2536
Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British journal of haematology, 174(2), pp. 255-263. Wiley-Blackwell 10.1111/bjh.14049
Taverna, Christian; Martinelli, Giovanni; Hitz, Felicitas; Mingrone, Walter; Pabst, Thomas; Cevreska, Lidija; Del Giglio, Auro; Vanazzi, Anna; Laszlo, Daniele; Raats, Johann; Rauch, Daniel; Vorobiof, Daniel A; Lohri, Andreas; Biaggi Rudolf, Christine; Rondeau, Stéphanie; Rusterholz, Corinne; Heijnen, Ingmar A F M; Zucca, Emanuele; Ghielmini, Michele (2016). Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. Journal of clinical oncology, 34(5), pp. 495-500. American Society of Clinical Oncology 10.1200/JCO.2015.61.3968
Mamot, Christoph; Klingbiel, Dirk; Hitz, Felicitas; Renner, Christoph; Pabst, Thomas; Driessen, Christoph; Mey, Ulrich; Pless, Miklos; Bargetzi, Mario; Krasniqi, Fatime; Gigli, Federica; Hany, Thomas; Samarin, Andrei; Biaggi, Christine; Rusterholz, Corinne; Dirnhofer, Stephan; Zucca, Emanuele; Martinelli, Giovanni (2015). Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07). Journal of clinical oncology, 33(23), pp. 2523-2529. American Society of Clinical Oncology 10.1200/JCO.2014.58.9846
Wannesson, Luciano; Bargetzi, Mario; Cairoli, Anne; Cerutti, Alessandra; Heim, Dominik; Hess, Urs; Lerch, Erika; Pabst, Thomas; Renner, Christoph; Samaras, Panagiotis; Zucca, Emanuele (2013). Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Leukemia & lymphoma, 54(1), pp. 36-40. London: Informa Healthcare 10.3109/10428194.2012.702903
Joerger, Markus; Ferreri, Andrés J M; Krähenbühl, Stephan; Schellens, Jan H M; Cerny, Thomas; Zucca, Emanuele; Huitema, Alwin D R (2012). Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate. British journal of clinical pharmacology, 73(2), pp. 240-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2125.2011.04084.x
Rinaldi, Andrea; Mian, Michael; Chigrinova, Ekaterina; Arcaini, Luca; Bhagat, Govind; Novak, Urban; Rancoita, Paola M. V.; De Campos, Cassio P.; Forconi, Francesco; Gascoyne, Randy D.; Facchetti, Fabio; Ponzoni, Maurilio; Govi, Silvia; Ferreri, Andrés J. M.; Mollejo, Manuela; Piris, Miguel A.; Baldini, Luca; Soulier, Jean; Thieblemont, Catherine; Canzonieri, Vincenzo; ... (2011). Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117(5), pp. 1595-1604. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-01-264275
Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Utiger, Urs; Cerny, Thomas; Hess, Urs; Bassi, Simona; Okkinga, Emmie; Stupp, Roger; Stahel, Rolf; Heizmann, Marc; Vorobiof, Daniel; Lohri, Andreas; Dietrich, Pierre-Yves; Zucca, Emanuele; Ghielmini, Michele (2010). Long Term Follow-Up Of Patients With Follicular Lymphoma Receiving Single Agent Rituximab At Two Different Schedules In Trial SAKK 35/98. Journal of clinical oncology, 28(29), pp. 4480-4484. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.28.4786
Novak, Urban; Rinaldi, Andrea; Kwee, Ivo; Nandula, Subhadra V; Rancoita, Paola M V; Compagno, Mara; Cerri, Michaela; Rossi, Davide; Murty, Vundavalli V; Zucca, Emanuele; Gaidano, Gianluca; Dalla-Favera, Riccardo; Pasqualucci, Laura; Bhagat, Govind; Bertoni, Francesco (2009). The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood, 113(20), pp. 4918-21. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-08-174110
Zucca, Emanuele; Davies, Andrew; Kryachok, Irina; Ciccone, Giovannino; Ceriani, Luca; Botto, Barbara; Mikhaeel, N. George; Dabrowska-Iwanicka, Anna; Zhao, Weili; Ionescu, Codruta; Janikova, Andrea; Fossa, Alexander; Hodgson, David; Jerkeman, Mats; Balzarotti, Monica; Tucci, Alessandra; Ricardi, Umberto; Barrington, Sally; Johnson, Peter W. M. and Martelli, Maurizio (10 June 2023). Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial. Journal of clinical oncology, 41(17_suppl), LBA7505-LBA7505. American Society of Clinical Oncology 10.1200/JCO.2023.41.17_suppl.LBA7505
Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Martinelli, Giovanni; Peccatori, F; Hess, Urs; Fey, Martin; Zucca, Emanuele; Stahel, Rolf; Ketterer, Nicolas; Cerny, Thomas (2009). Long-term follow-up of patients with follicular lymphoma (FL) receiving single agent rituximab at two different schedules in study SAKK 35/98. Journal of clinical oncology, 27(15), p. 8512. American Society of Clinical Oncology
